STOCKHOLM--Swedish buyout group EQT led a series B funding extension for Swiss biotech company Noema Pharma. Noema Pharma is developing a pipeline of therapeutics that address central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback